What You Should Know About Peptides (the ones being sold to you online)

Written By Charles Becker MD

Scroll through Instagram or TikTok for ten minutes and you'll find influencers, gyms, telehealth clinics, and "longevity coaches" pushing injectable "peptides" for everything from weight loss to anti-aging to muscle recovery to better sleep. The marketing is slick. The before-and-after photos are compelling. The science backing most of these compounds, in humans, is almost entirely absent.

I want to walk you through three things: what peptides actually are, how they've earned a real and important place in modern medicine, and why the specific category of "peptide therapy" being sold on social media deserves serious skepticism — even when the molecule itself sounds impressive.


What is a peptide?

A peptide is just a short chain of amino acids — the building blocks of proteins. Your body produces hundreds of them every day to carry out essential signaling work: regulating blood sugar, controlling appetite, managing blood pressure, telling you when to sleep and when to wake up.

A peptide works by binding to a specific receptor on the surface of a cell — picture a key sliding into a lock. When the key turns, the cell carries out a specific action: releasing insulin, suppressing appetite, dilating a blood vessel. Most of the chemistry of being alive runs on this kind of signaling.

Insulin is the most familiar example. Without it, your cells can't pull glucose out of the bloodstream to use as fuel — which is why people with type 1 diabetes can't survive without insulin replacement. Other example: ghrelin and leptin (which regulate hunger and satiety), oxytocin (involved in labor and bonding), and brain natriuretic peptide (released by a stressed heart to help the kidneys offload fluid). These aren't exotic drugs — they're how your body talks to itself.


Peptides as medicine: a hundred-year history

The story of peptide therapeutics starts in 1922 in Toronto, when Frederick Banting and Charles Best extracted insulin from cow and pig pancreases and successfully gave it to a 14-year-old boy with type 1 diabetes. A condition that had been a swift death sentence became a chronic, manageable disease. Sixty years later, in 1982, scientists inserted the human gene for insulin into E. coli bacteria, turning the bacteria into tiny insulin factories — a leap that made large-scale, consistent, human-identical peptide production possible.

Since then we've seen an explosion of peptide drugs: analogs of our own hormones (oxytocin to induce labor, calcitonin for certain bone conditions), molecules borrowed from other organisms (bacitracin, the topical antibiotic in your medicine cabinet, was originally isolated from soil bacteria), and entirely lab-designed peptides built to fit human receptors in useful ways. Peptide therapeutics are a legitimate growing area of medicine.


GLP-1 receptor agonists: peptide medicine in the spotlight

The peptides most people have heard of are the GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro, Zepbound. They are everywhere in popular culture right now, and for good reason.

The mechanism. When you eat a meal, your gut releases a hormone called GLP-1 (glucagon-like peptide-1), one of the body's "incretin" hormones. GLP-1 does several useful things at once: it tells the pancreas to release insulin, but only when blood sugar is actually elevated (which makes it safer than insulin alone); it suppresses a counter-regulatory hormone called glucagon; it slows the rate at which your stomach empties; and it signals to your brain that you're full. Native GLP-1 is broken down within minutes by an enzyme called DPP-4, which is why your body has to release it constantly during a meal.GLP-1 receptor agonists are engineered to do the same job, but for much, much longer. Semaglutide — the active ingredient in Ozempic and Wegovy — shares about 94% of its amino acid sequence with native human GLP-1, with three small but critical modifications which protect it from breakdown and create a longer-lasting, persistent effect. The result is a half-life of roughly a week, which is why patients can dose once weekly instead of releasing GLP-1 minute by minute the way the body normally does. PubMed Central + 2

The evidence. This is the part that matters most. GLP-1 agonists have been studied in tens of thousands of patients across dozens of randomized controlled trials over roughly two decades. We have clear data on glycemic control in diabetes, substantial and sustained weight loss in obesity, and — increasingly — benefits well beyond either. The SELECT trial enrolled 17,604 adults with overweight or obesity and established cardiovascular disease (but no diabetes), and showed that semaglutide reduced major adverse cardiovascular events by 20%. A pre-specified kidney analysis from the same trial showed meaningful reduction in adverse kidney outcomes, and semaglutide is now approved specifically for slowing kidney disease progression in diabetic patients with chronic kidney disease. There are some other potential use cases for these medications- some approved and some still being studied- including treatment of alcohol use disorder and obstructive sleep apnea. nihnih

The limits. None of this means GLP-1s are perfect. They cause nausea, vomiting, and other GI side effects, sometimes badly enough that patients can't tolerate them. They're expensive. We're still learning about long-term effects on muscle mass and bone density, and what happens when patients stop taking them (most regain weight). But the point is that we know these things, because these drugs have been studied properly. That distinction is what the next section is about.

The injectable peptide boom

Walk into the wellness corner of social media and you'll find a different kind of peptide entirely: BPC-157 marketed for tendon injuries, CJC-1295 and ipamorelin for "growth hormone optimization," TB-500 for recovery, Melanotan II for tanning, AOD-9604 for fat loss, MOTS-c for "cellular energy." These typically come from compounding pharmacies, "research chemical" suppliers, or shadier corners of the international market.

A quick but important distinction: these injectable powder peptides are not the same thing as the dietary peptides sometimes promoted in food and supplements (collagen, milk-derived peptides, soy peptides, etc.). Those are eaten, mostly broken down into individual amino acids during digestion, and at worst do nothing. Injectable peptides are potent, targeted compounds delivered directly into your tissues. The risk profile is entirely different.

Two questions cut through all the marketing.


Does it actually work?

For almost all of the injectable peptides being sold online, the honest answer is we have no idea. Take BPC-157, perhaps the most famous of them, marketed widely for tendon and joint healing. As of early 2026, only three small pilot studies have been published in humans — none of them randomized or placebo-controlled, with fewer than thirty total subjects across all of them combined. A larger Phase I trial planned in 2015 was cancelled and never reported results. There's interesting animal data, but animal data is hypothesis-generating, not evidence of human benefit. Compounds that look promising in mice fail in human trials all the time — that's why we do human trials. Peptide Database

What gets marketed as "clinical evidence" for most of these peptides turns out, on inspection, to be one of three things: animal studies, in-vitro work in cell culture, or small uncontrolled case series often published by the same clinicians selling the product. None of that comes close to meeting the bar for recommending an injectable medication.

Is it safe?

Here the gap between marketing and reality is even wider. To use a peptide responsibly, you need to know:

  • What's actually in the vial. Gray-market and improperly compounded peptides routinely have purity and potency problems. You don't always know whether you're getting the labeled compound, how much of it, or what else came along for the ride — endotoxins, heavy metals, residual solvents from synthesis.

  • Whether it's sterile. Injectables that aren't manufactured under pharmaceutical-grade conditions can cause abscesses, bloodstream infections, and worse.

  • What the side effects actually are at the dose you're taking. For most of these compounds, we don't have systematic human safety data — let alone in people on other medications, with chronic conditions, or who are pregnant.

  • What the long-term risks are. BPC-157, for example, promotes blood vessel formation (angiogenesis), which raises a theoretical concern about cancer promotion that has not been studied in humans. We don't know whether the concern is real. We also don't know that it isn't.

Conventional medications operate inside a system — imperfect, but real — that requires evidence of efficacy, controlled manufacturing, sterility testing, defined dosing, and ongoing reporting of adverse events. The injectable peptides sold online operate almost entirely outside that system. That isn't a paperwork problem. It's the difference between a substance that's been studied seriously enough to know whether it helps or harms you, and one that hasn't.

The bottom line

Peptide medicine is real, mature, and still advancing. GLP-1 receptor agonists are an excellent example of what the field looks like when it's done right: a clear mechanism, decades of trials, hundreds of thousands of treated patients, growing evidence of benefit well beyond the original indication, and a known and managed side effect profile. That's the standard.

The injectable peptides being sold on social media for muscle gain, anti-aging, recovery, and "optimization" are not held to that standard. Most have never been tested in a proper human trial. The sourcing is opaque. The long-term risks are unstudied. The clinics and influencers promoting them are often the same people selling them.

If you're considering one of these, ask the person recommending it: Where is the randomized controlled trial in humans? Who manufactures this and how is it tested? What's actually known about it? If you can't get straight answers, that itself is the answer.

I'm not against new medicine — peptide therapeutics may yet produce some of the most exciting treatments of the next decade. What I'm against are the grifters who exploit the real, well-founded distrust of the healthcare system by marketing "peptides" as an easy solution for health optimization. There are no easy solutions in medicine- only people willing to sell you one.


Charles Becker MD
Next

The Coronary Artery Calcium Score: What it is, Why it Matters, and Whether You Should Get One